Literature DB >> 19932848

Histological differentiation of primary oral squamous cell carcinomas in an area of betel quid chewing prevalence.

Ku-Hao Fang1, Huang-Kai Kao, Ming-Hui Cheng, Yu-Liang Chang, Ngan-Ming Tsang, Yu-Chen Huang, Li-Yu Lee, Jau-Song Yu, Sheng-Po Hao, Kai-Ping Chang.   

Abstract

OBJECTIVES: This study evaluated associations between the histological differentiation of oral squamous cell carcinoma and additional clinicopathological manifestations, adverse events after treatment, and the outcomes of patients in a region prevalent for betel quid chewing. STUDY
DESIGN: Case series with chart review.
SETTING: Tertiary referral center. SUBJECTS AND METHODS: A total of 150 patients with primary oral squamous cell carcinomas who underwent surgery with or without adjuvant therapy were enrolled.
RESULTS: Well, moderate, and poorly differentiated oral squamous cell carcinomas were reported in 54 (36%), 84 (56%), and 12 (8%) patients, respectively. There were no significant differences among different histological differentiations in age, sex, tumor, node, metastasis stage, bone invasion, depth of invasion, and history of carcinogen exposure. However, we found significant associations between tumor histological differentiation and nodal metastasis (P < 0.0001), extracapsular spread (P = 0.002), and perineural invasion (P < 0.0001). In the analysis of adverse events for survival during patient follow-up, oral squamous cell carcinomas with poor differentiation had a higher probability of developing neck recurrence (P = 0.001) and distant metastasis (P = 0.019), but not local recurrence or a second primary cancer. For survival analysis, univariate analysis showed that patient age, tumor stage, extracapsular spread, presence of perineural invasion, and tumor differentiation were significant factors. Multivariate analysis further demonstrated that poor differentiation (P = 0.007) was still a statistically significant factor.
CONCLUSION: The current study demonstrates that poorer tumor histological classifications of oral squamous cell carcinoma are significantly associated with positive nodal status, extracapsular spread, perineural invasion of primary tumors, and the probability of developing neck recurrence and distant metastasis after treatment.

Entities:  

Mesh:

Year:  2009        PMID: 19932848     DOI: 10.1016/j.otohns.2009.09.012

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  16 in total

1.  Assessment of Histopathological Grade and Ki-67 Expression in Tobacco and Non-tobacco Habitual Buccal Mucosa Cancer.

Authors:  Ramasamy Padma; Sivapatham Sundaresan; Amitkumar Kalaivani; Ramamurthy Thilagavathi
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-04-06

Review 2.  Prognostic Stratification of Patients With Advanced Oral Cavity Squamous Cell Carcinoma.

Authors:  Dante De Paz; Huang-Kai Kao; Yenlin Huang; Kai-Ping Chang
Journal:  Curr Oncol Rep       Date:  2017-08-10       Impact factor: 5.075

Review 3.  Distant metastasis from oral cavity-correlation between histopathology results and primary site.

Authors:  Yuka Uchiyama; Tadashi Sasai; Atsutoshi Nakatani; Hiroaki Shimamoto; Tomomi Tsujimoto; Sven Kreiborg; Shumei Murakami
Journal:  Oral Radiol       Date:  2020-05-28       Impact factor: 1.852

4.  Estimation of plasma lipids and its significance on histopathological grades in oral cancer: Prognostic significance an original research.

Authors:  Eugenia J Sherubin; Karthiga S Kannan; Dhineksh N Kumar; Isaac Joseph
Journal:  J Oral Maxillofac Pathol       Date:  2013-01

5.  Modified Tumor Classification With Inclusion of Tumor Characteristics Improves Discrimination and Prediction Accuracy in Oral and Hypopharyngeal Cancer Patients Who Underwent Surgery.

Authors:  Ching-Chih Lee; Hsu-Chueh Ho; Yu-Chieh Su; Chia-Hui Yu; Ching-Chieh Yang
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

6.  Low-molecular-mass secretome profiling identifies HMGA2 and MIF as prognostic biomarkers for oral cavity squamous cell carcinoma.

Authors:  Kai-Ping Chang; Shih-Jie Lin; Shiau-Chin Liu; Jui-Shan Yi; Kun-Yi Chien; Lang-Ming Chi; Huang-Kai Kao; Ying Liang; Yu-Tsun Lin; Yu-Sun Chang; Jau-Song Yu
Journal:  Sci Rep       Date:  2015-07-03       Impact factor: 4.379

7.  Preoperative SCC Antigen, CRP Serum Levels, and Lymph Node Density in Oral Squamous Cell Carcinoma.

Authors:  Mohamad Adel; Chung-Kan Tsao; Fu-Chan Wei; Huei-Tzu Chien; Chih-Hsiung Lai; Chun-Ta Liao; Hung-Ming Wang; Kang-Hsing Fan; Chung-Jan Kang; Joseph Tung-Chieh Chang; Shiang-Fu Huang
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

8.  Evaluation of Lymphatic and Vascular Invasion in Relation to Clinicopathological Factors and Treatment Outcome in Oral Cavity Squamous Cell Carcinoma.

Authors:  Mohamad Adel; Huang-Kai Kao; Cheng-Lung Hsu; Jung-Ju Huang; Li-Yu Lee; Yenlin Huang; Timothy Browne; Ngan-Ming Tsang; Yu-Liang Chang; Kai-Ping Chang
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

9.  A genetic programming approach to oral cancer prognosis.

Authors:  Mei Sze Tan; Jing Wei Tan; Siow-Wee Chang; Hwa Jen Yap; Sameem Abdul Kareem; Rosnah Binti Zain
Journal:  PeerJ       Date:  2016-09-21       Impact factor: 2.984

10.  ASC contributes to metastasis of oral cavity squamous cell carcinoma.

Authors:  Chi-Sheng Wu; Kai-Ping Chang; Chun-Nan OuYang; Huang-Kai Kao; Chuen Hsueh; Lih-Chyang Chen; Hsiao-Yun Cheng; Ying Liang; Willisa Liou; Chih-Lung Liang; Yu-Sun Chang
Journal:  Oncotarget       Date:  2016-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.